Table 3.
Summary of GRADE on evidences of outcomes of Bu-yang Huan-wu decoction for acute ischemic stroke.
| Quality assessment | Number of patients | Effect | Quality | Importance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Trial | Control | Relative (95% CI) |
Absolute | ||
| Effective rate | ||||||||||||
|
| ||||||||||||
| 17 | Randomized trials | Very serious | No serious inconsistency | No serious indirectness | No serious imprecision | Reporting bias | 696/747 (93.2%) | 535/697 (76.8%) | RR 1.18 (1.12 to 1.24) |
138 more per 1000 (from 92 more to 184 more) | ⨁ ○○○ very low | Important |
| 75% | 135 more per 1000 (from 90 more to 180 more) | |||||||||||
|
| ||||||||||||
| Neurological deficit scores (Modified Edinburgh–Scandinavian Stroke Scale) | ||||||||||||
|
| ||||||||||||
| 9 | Randomized trials | Very serious | No serious inconsistency | No serious indirectness | No serious imprecision | Reporting bias | 409 | 377 | — | MD 4.65 lower (6.57 to 2.72 lower) | ⨁ ○○○ very low | Important |
|
| ||||||||||||
| Neurological deficit scores (ESS) | ||||||||||||
|
| ||||||||||||
| 1 | Randomized trials | Very serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 33 | 33 | — | MD 7.99 higher (3.96 to 12.02 higher) | ⨁⨁ ○○ low | Important |